Addex Therapeutics Q2 EPS $(1.52) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY

Benzinga Newsdesk www.benzinga.com Negative 93.7%

Neg 93.7% Neu 0% Pos 0%

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.52) per share. This is a 47.59 percent increase over losses of $(2.90) per share from the same period last year. The company reported $12.650 thousand in sales this quarter. This is a 71.27 percent decrease over sales of $44.031 thousand the same period last year.